BOSTON, Jan. 8, 2026 /PRNewswire/ — eschbach, provider of the intelligent operations platform Shiftconnector®, has received the 2026 IoT Breakthrough Award for its AI-powered innovation, SAMI Chat, at ...

The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...

MSD is a company that is ‘serious about science.’ In 2024, its global research and development investment reached $17.9 ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...

Equity-Insider.com News Commentary – Biopharma M&A is entering a fever pitch, with precision oncology investments alone exploding to $138 billion as major players scramble to secure proven cancer ...

CareTria, formerly Knipper Health, rebranded to enhance its comprehensive therapy initiation platform, integrating digital onboarding and multi-modal fulfillment. The acquisition of eBlu Solutions ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Impella, which J&J touts as the world’s smallest heart pump, has a range of devices used for various heart conditions. Lexeo ...

Octapharma has received approval from the US Food and Drug Administration (FDA) for a new 2-gram (g) formulation of Fibryga ...

Focusing on 2026 as a starting point, PwC has laid out several “strategic imperatives” pharma companies ought to pursue this ...

Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...

Cash management is critical for pharmaceutical companies: The ability to fund drug innovation can make the difference between ...